Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease

EJ Topol, D Easton, RA Harrington, P Amarenco, RM Califf, C Graffagnino, S Davis, HC Diener, J Ferguson, D Fitzgerald, J Granett, A Shuaib, PJ Koudstaal, P Theroux, F Van de Werf, K Sigmon, K Pieper, M Vallee, JT Willerson